Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V260 (RotaTeq) in Healthy Chinese Infants
NCT02062385Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- May 2014
- Primary completion
- Jun 2015
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of rotavirus vaccine, live, oral, pentavalent in rotavirus gastroenteritis, sponsored by Merck & Co.. Started May 2014; status: completed.
02
Drugs
rotavirus vaccine, live, oral, pentavalent
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT02062385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02062385.